2003, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, 2003

Aarli JA, Romi F, Skeie GO, Gilhus NE 2003 Myasthenia gravis in individuals over 40. Ann. N. Y. Acad. Sci. 998: 424-431.
Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI 2003 Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 4: 450-454. *
Abdel-Ghaffar YT, Amin E, Abdel-Rasheed M, Fouad HH 2003 Essential fatty acid status in infants and children with chronic liver disease. East. Mediterr. Health J. 9: 61-69.
Abdo A, Klassen J, Urbanski S, Raber E, Swain MG 2003 Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J. Hepatol. 38: 688-691. *
Abdo AA, Beck P 2003 Diagnosis and management of microscopic colitis. Can. Fam. Physician 49: 1473-1478.
Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, Horiike N, Onji M 2003 Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern. Med. 42: 48-52. *
Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H 2003 Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am. J. Pathol. 162: 1515-1520. *
Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, Nakashima K, Takagi N, Baba H, Hasegawa Y, Shimokata K 2003 NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J. Infect. 46: 215-220.
Abei M, Tanaka N 2003 Prevention of black pigment gallstone formation after cardiac surgery by ursodeoxycholic acid. J. Gastroenterol. 38: 1113-1115. *
Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR 2003 Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125: 320-327. *
Abid S 2003 Helicobacter pylori: what test for diagnosis and what treatment for eradication? J. Pak. Med. Assoc. 53: 88-89.
Aboutwerat A, Pemberton PW, Smith A, Burrows PC, McMahon RF, Jain SK, Warnes TW 2003 Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim. Biophys. Acta 1637: 142-150. *
Abraham E 2003 Computational design of variant TNF molecules: a novel methodology for inhibition of proinflammatory cascades. Sci. STKE 208: PE51. *
Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK 2003 Diffuse lymphoplasmacytic chronic cholecystitis is highly specific for extrahepatic biliary tract disease but does not distinguish between primary and secondary sclerosing cholangiopathy. Am. J. Surg. Pathol. 27: 1313-1320.
Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK 2003 Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am. J. Surg. Pathol. 27: 441-451.
Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH 2003 Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am. J. Surg. Pathol. 27: 110-120.
Abrantes EF, Pires EG, Carvalho AF, Costa FF, Savino W, Reis LF 2003 Identification, structural characterization, and tissue distribution of Tsg-5: a new TNF-stimulated gene. Genes Immun. 4: 298-311. *
Abreu MT 2003 Immunologic regulation of Toll-like receptors in gut epithelium. Curr. Opin. Gastroenterol. 19: 559-564.
Abu-Abed S, Dolle P, Metzger D, Wood C, MacLean G, Chambon P, Petkovich M 2003 Developing with lethal RA levels: genetic ablation of Rarg can restore the viability of mice lacking Cyp26a1. Development 130: 1449-1459. *
Abu-Mouch S, Selmi C, Benson GD, Kenny TP, Invernizzi P, Zuin M, Podda M, Rossaro L, Gershwin ME 2003 Geographic clusters of primary biliary cirrhosis. Clin. Dev. Immunol. 10: 127-131. *
Ackerman HC, Ribas G, Jallow M, Mott R, Neville M, Sisay-Joof F, Pinder M, Campbell RD, Kwiatkowski DP 2003 Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun. 4: 476-486. *
Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D 2003 Experimental colitis in rats with portal hypertension and liver disease. Inflamm. Bowel Dis. 9: 18-24. *
Acuto O, Michel F 2003 CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3: 939-951.
Adam O 2003 Dietary fatty acids and immune reactions in synovial tissue. Eur. J. Med. Res. 8: 381-387.
Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W 2003 Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int. 23: 27-36. *
Adams DD, Knight JG 2003 Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy. J. Clin. Lab. Immunol. 52: 1-22.
Adams DH, Afford SC, Lalor PF 2003 Cellular immunoreactions in the development of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 27. October 15-16. *
Adani GL, Baccarani U, Risaliti A, Donini A, Aoki T, Avital I 2003 Appendicectomy and Crohn's disease: clinical and genetic associations. Gastroenterology 125: 1562-1563. *
Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ 2003 The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun. 4: 420-426. *
Adibi SA 2003 Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G779-G788. *
Adler G, Reinshagen M; German Society for Digestive and Metabolic Diseases 2003 Extraintestinal manifestations. Z. Gastroenterol. 41: 54-61.
Afolabi AO 2003 Recurrent leg ulcers in a 16-year old Nigerian girl. Afr. J. Med. Med. Sci. 32: 93-94.
Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, Mischung C, Kusuhara K, Saulsbury FT, Lachmann HJ, Bybee A, McDermott EM, La Regina M, Arostegui JI, Campistol JM, Worthington S, High KP, Molloy MG, Baker N, et al 2003 Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 48: 2632-2644. *
Agarwal B, Swaroop P, Protiva P, Raj SV, Shirin H, Holt PR 2003 Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Apoptosis 8: 649-654. *
Aggarwal A, Ong JP, Goormastic M, Nelson DR, Arroliga AC, Farquhar L, Mayes J, Younossi ZM 2003 Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit. Transplant. Proc. 35: 2998-3002. *
Aggarwal BB 2003 Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756. *
Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL 2003 Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914. *
Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, Movahedi M, Gharagozlou M, Atarod L, Ahmadi Afshar A, Bazargan N, Abolmaali K, Mahmoudi M 2003 Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency. Iran. J. Allergy Asthma Immunol. 2: 121-126.
Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP 2003 Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am. J. Gastroenterol. 98: 348-353. *
Agnholt J, Dahlerup JF, Buntzen S, Tottrup A, Nielsen SL, Lundorf E 2003 Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease. Aliment. Pharmacol. Ther. 17: 703-710. *
Agnholt J, Dahlerup JF, Kaltoft K 2003 The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures. Cytokine 23: 76-85. *
Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ 2003 Osteopontin identified as colon cancer tumor progression marker. C.R. Biol. 326: 1041-1043.
Aguilar F, Nunez-Roldan A, Torres B, Wichmann I, Sanchez-Roman J, Gonzalez-Escribano MF 2003 Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770-1774.
Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A, Gonzalez-Escribano MF 2003 CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum. Immunol. 64: 936-940.
Aguillon JC, Contreras J, Dotte A, Cruzat A, Catalan D, Salazar L, Molina MC, Guerrero J, Lopez M, Soto L, Salazar-Onfray F, Cuchacovich M 2003 New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies. Rev. Med. Chil. 131: 1445-1453.
Ahmad A, Govil Y, Frank BB 2003 Gastric mucosa-associated lymphoid tissue lymphoma. Am. J. Gastroenterol. 98: 975-986. *
Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP 2003 The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62: 527-535. *
Ahmad T, Marshall S, Jewell D 2003 Genotype-based phenotyping heralds a new taxonomy for inflammatory bowel disease. Curr. Opin. Gastroenterol. 19: 327-335.
Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, Sato H, Ling KL, Barnardo M, Goldthorpe S, Walton R, Bunce M, Jewell DP, Welsh KI 2003 Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum. Mol. Genet. 12: 647-656. *
Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP 2003 Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 48: 807-813. *
Ahmadi KR, Lanchbury JS, Reed P, Chiano M, Thompson D, Galley M, Line A, Lank E, Wong HJ, Strachan D, Spector TD 2003 Novel association suggests multiple independent QTLs within chromosome 5q21-33 region control variation in total humans IgE levels. Genes Immun. 4: 289-297. *
Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P 2003 Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52: 1159-1164. *
Ahmed SS, Tan FK 2003 Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations. Curr. Opin. Rheumatol. 15: 766-771.
Ahuja HS, Szanto A, Nagy L, Davies PJ 2003 The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. J. Biol. Regul. Homeost. Agents 17: 29-45.
Ai T, Azemoto R, Saisho H 2003 Prevention of gallstones by ursodeoxycholic acid after cardiac surgery. J. Gastroenterol. 38: 1071-1076. *
Aires V, Hichami A, Moutairou K, Khan NA 2003 Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br. J. Pharmacol. 140: 1217-1226. *
Ajit C, Suvannasankha A, Zaeri N, Munoz SJ 2003 Terbinafine-associated hepatotoxicity. Am. J. Med. Sci. 325: 292-295.
Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowden DW 2003 Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. J. Hum. Genet. 48: 236-242. *
Akin K, Beyler AR, Kaya M, Erden E 2003 The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis. Turk. J. Gastroenterol. 14: 228-233. *
Akira S 2003 Mammalian Toll-like receptors. Curr. Opin. Immunol. 15: 5-11.
Akira S, Hemmi H 2003 Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85-95.
Akira S, Hoshino K 2003 Myeloid differentiation factor 88-dependent and -independent pathways in Toll-like receptor signaling. J. Infect. Dis. 187 Suppl. 2: S356-S363. *
Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S, Casanova JL, Thomas C, Vilmer E, Fischer A, Bertrand Y; French Langerhans Cell Study Group 2003 Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant. 31: 1097-1103.
Akoume MY, Perwaiz S, Yousef IM, Plaa GL 2003 Synergistic role of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7alpha-hydroxylase in the pathogenesis of manganese-bilirubin-induced cholestasis in rats. Toxicol. Sci. 73: 378-385. *
Al-Jabri AA, Al Belushi MS, Nsanze H 2003 Frequency and levels of autoantibodies in healthy adult Omanis. Ann. Saudi Med. 23: 372-375.
Alarcon-Riquelme ME 2003 A RUNX trio with a taste for autoimmunity. Nat. Genet. 35: 299-300. *
Alba LM, Lindor K 2003 Review article: non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 17: 977-986. *
Albanis E, Safadi R, Friedman SL 2003 Treatment of hepatic fibrosis: almost there. Curr. Gastroenterol. Rep. 5: 48-56.
Albers R, Bol M, Bleumink R, Willems AA, Pieters RH 2003 Effects of supplementation with vitamins A, C, and E, selenium, and zinc on immune function in a murine sensitization model. Nutrition 19: 940-946. *
Albrecht J 2003 Glucose-derived osmolytes and energy impairment in brain edema accompanying liver failure: the role of glutamine reevaluated. Gastroenterology 125: 976-978. *
Albrecht M, Domingues FS, Schreiber S, Lengauer T 2003 Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett. 554: 520-528. *
Albrecht M, Domingues FS, Schreiber S, Lengauer T 2003 Identification of mammalian orthologs associates PYPAF5 with distinct functional roles. FEBS Lett. 538: 173-177. *
Albrecht M, Lengauer T, Schreiber S 2003 Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence. Bioinformatics 19: 2171-2175. *
Alcami A 2003 Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3: 36-50. *
Aldemir M, Faruk Gey I K M, Faruk Kokoglu O, Buyukbayram HI, Hosoglu SI, Yagmur Y 2003 Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats. ANZ J. Surg. 73: 722-726. *
Aldhous MC, Nimmo ER, Satsangi J 2003 NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease. Gut 52: 1533-1535. *
Alfadhli AA, McDonald JW, Feagan BG 2003 Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst. Rev. 1: CD003459. *
Alfke H, Alfke B, Froelich JJ, Klose KJ, Wagner HJ 2003 Treatment of malignant biliary occlusion by means of transhepatic percutaneous biliary drainage with insertion of metal stents - results of an 8-year follow-up and analysis of the prognostic parameters. Rofo. 175: 1125-1129.
Alison MR 2003 Characterization of the differentiation capacity of rat-derived hepatic stem cells. Semin. Liver Dis. 23: 325-336.
Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, et al 2003 Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann. Neurol. 54: 119-122. *
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA 2003 Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16: 208-214. *
Allen A, Obaro S, Bojang K, Awomoyi AA, Greenwood BM, Whittle H, Sirugo G, Newport MJ 2003 Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr. Infect. Dis. J. 22: 1018-1019.
Allen JD, Van Dort SC, Buitelaar M, van Tellingen O, Schinkel AH 2003 Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Cancer Res. 63: 1339-1344. *
Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, Ponting CP, Bhattacharyya S, Tinsley J, Zhang Y, Holt R, Jones EY, Lench N, Carey A, Jones H, Dickens NJ, Dimon C, Nicholls R, Baker C, Xue L, Townsend E, Kabesch M, Weiland SK, Carr D et al 2003 Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35: 258-263. *
Allgayer H 2003 Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18 Suppl. 2: 10-14. *
Allgayer H, Kruis W 2003 PPAR-ligands: a clinically important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer? Z. Gastroenterol. 41: 1035-1038.
Alonso D, Elgart GW, Schachner LA 2003 Blau syndrome: a new kindred. J. Am. Acad. Dermatol. 49: 299-302.
Alper CA, Xu J, Cosmopoulos K, Dolinski B, Stein R, Uko G, Larsen CE, Dubey DP, Densen P, Truedsson L, Sturfelt G, Sjoholm AG 2003 Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J. Clin. Immunol. 23: 297-305.
Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C 2003 Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst. Rev. 2: CD001939. *
Alsaeid K, Haider MZ, Ayoub EM 2003 Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis. J. Rheumatol. 30: 2705-2709.
Alsaeid KM, Haider MZ, al-Awadhi AM, Srivastva BS, Ayoub EM 2003 Role of human leukocyte antigen DRB1*0307 and DRB1*0308 in susceptibility to juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 399-402.
Alstead EM, Nelson-Piercy C 2003 Inflammatory bowel disease in pregnancy. Gut 52: 159-161. *
Alzoghaibi MA, Walsh SW, Willey A, Fowler Iii AA, Graham MF 2003 Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin. Nutr. 22: 529-535. *
Amano M, Galvan M, He J, Baum LG 2003 The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J. Biol. Chem. 278: 7469-7475. *
Amante MF, Trigo P, Lendoire J, Imventarza O, Parisi C 2003 Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers. Ann. Hepatol. 2: 171-174. *
Amarapurkar DN, Patel ND, Amarapurkar AD 2003 Hepatic sarcoidosis. Indian J. Gastroenterol. 22: 98-100.
Amarapurkar DN, Patel ND, Amarapurkar AD, Kankonkar SR 2003 HLA genotyping in type-I autoimmune hepatitis in Western India. J. Assoc. Physicians India 51: 967-969.
Amat di San Filippo C, Wang Y, Longo N 2003 Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency. J. Biol. Chem. 278: 47776-47784. *
Amati L, Caradonna L, Leandro G, Magrone T, Minenna M, Faleo G, Pellegrino NM, Jirillo E, Caccavo D 2003 Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects. Curr. Pharm. Design 9: 1937-1945.
Ambrosino G, Naso A, Feltracco P, Carraro P, Basso SM, Varotto S, Cillo U, Zanus 2003 Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS). Acta Biomed. Ateneo Parmense 74 Suppl. 2: 7-9.
American Gastroenterological Association 2003 American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 125: 937-940. *
American Gastroenterological Association Clinical Practice Committee 2003 American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 125: 1503-1507. *
Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pita O, Puddu P 2003 Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr. Drug Targets Inflamm. Allergy 2: 81-94.
Amre DK, Seidman EG 2003 DNA variants in cytokine and NOD2 genes, exposures to infections and risk for Crohn's disease. Paediatr. Perinat. Epidemiol. 17: 302-312.
Amsaguine-Safir S, Bianchi A, Collet P, Huin-Schohn C, Jeanvoine A, Becuwe P, Kremarik-Bouillaud P, Domenjoud L, Keller JM, Schohn H, Dauca M 2003 Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues. Microsc. Res. Tech. 61: 185-190. *
Anagnostopoulos GK, Margantinis G, Tsiakos S, Kostopoulos P, Pantes A, Arvanitidis D 2003 Myopericarditis associated with ulcerative colitis. N. Z. Med. J. 116: U667.
Anakk S, Kalsotra A, Shen Q, Vu MT, Staudinger JL, Davies PJ, Strobel HW 2003 Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. FASEB J. 17: 1736-1738. *
Anand AC 2003 Bioartificial liver support for fulminant hepatic failure. Indian J. Gastroenterol. 22 Suppl. 2: S69-S74.
Anantharaju A, Baluch M, Van Thiel DH 2003 Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig. Dis. Sci. 48: 830-833. *
Anastassopoulou CG, Kostrikis LG 2003 The impact of human allelic variation on HIV-1 disease. Curr. HIV Res. 1: 185-203.
Anaya JM, Rivera D, Palacio LG, Arcos-Burgos M, Correa PA 2003 D6S439 microsatellite identifies a new susceptibility region for primary Sjogren's syndrome. J. Rheumatol. 30: 2152-2156.
Anderson P, May B, Morris H 2003 Vitamin D metabolism: new concepts and clinical implications. Clin. Biochem. Rev. 24: 13-26. *
Anderson P, Sundstedt A, Li L, O'Neill EJ, Li S, Wraith DC, Wang P 2003 Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Int. Immunol. 15: 1309-1317. *
Anderson WF, Umar A, Hawk ET 2003 Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin. Pharmacother. 4: 2193-2204.
Andersson P, Olaison G, Hallbook O, Boeryd B, Sjodahl R 2003 Increased anal resting pressure and rectal sensitivity in Crohn's disease. Dis. Colon Rectum 46: 1685-1689.
Andersson RE, Olaison G, Tysk C, Ekbom A 2003 Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124: 40-46. *
Andersson U, Tracey KJ 2003 HMGB1 in sepsis. Scand. J. Infect. Dis. 35: 577-584.
Andoh A, Tsujikawa T, Fujiyama Y 2003 Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharm. Des. 9: 347-358.
Andoh A, Tsujikawa T, Ishizuka I, Araki Y, Sasaki M, Koyama S, Fujiyama Y 2003 n-3 Fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int. J. Mol. Med. 12: 721-725. *
Andrault JB, Gaillard I, Giorgi D, Rouquier S 2003 Expansion of the BPI family by duplication on human chromosome 20: characterization of the RY gene cluster in 20q11.21 encoding olfactory transporters/antimicrobial-like peptides. Genomics 82: 172-184. *
Andreeva-Gateva P 2003 Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism. Ann. Biol. Clin. (Paris) 61: 295-303.
Andrews T, Sullivan KE 2003 Infections in patients with inherited defects in phagocytic function. Clin. Microbiol. Rev. 16: 597-621. *
Andrieu T, Thibault V, Malet I, Laporte J, Bauvois B, Agut H, Cahour A 2003 Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. J. Clin. Virol. 27: 59-68.
Andus T, Gross V, Caesar I, Schulz HJ, Lochs H, Strohm WD, Gierend M, Weber A, Ewe K, Scholmerich J; German/Austrian Budesonide Study Group 2003 Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial. Dig. Dis. Sci. 48: 373-378. *
Andus T, Klebl F, Rogler G, Bregenzer N, Scholmerich J, Straub RH 2003 Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Aliment. Pharmacol. Ther. 17: 409-414. *
Andus T, Stange EF, Hoffler D, Keller-Stanislawski B 2003 Suspected cases of severe side effects after infliximab (Remicade) in Germany. Med. Klin. (Munich) 98: 429-436.
Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, Baldwin AS 2003 A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663. *
Ang HT, Helfgott S 2003 Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis? J. Rheumatol. 30: 2315-2318.
Ang TL, Fock KM, Ng TM, Teo EK, Tan YL 2003 Clinical utility, safety and tolerability of capsule endoscopy in urban Southeast Asian population. World J. Gastroenterol. 9: 2313-2316. *
Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M 2003 Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52: 879-885. *
Angio LG, Pirrone G, Rivoli G, Fracassi MG, Rosato A, Piazzese E, Pacile V, Sfuncia G, Fiumara F 2003 Pyoderma gangrenosum of the "sinus mammarum" in ulcerative colitis. G. Chir. 24: 247-254.
Angulo P 2003 Non-alcoholic steatohepatitis. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 87-88. October 17 - 19. *
Angulo P 2003 Current best treatment for non-alcoholic fatty liver disease. Expert Opin. Pharmacother. 4: 611-623.
Annacker O, Asseman C, Read S, Powrie F 2003 Interleukin-10 in the regulation of T cell-induced colitis. J. Autoimmun. 20: 277-279.
Annese V, Latiano A, Andriulli A 2003 Genetics of inflammatory bowel disease: the beginning of the end or the end of the beginning? Dig. Liver Dis. 35: 442-449.
Annese V, Latiano A, Palmieri O, Li HH, Forabosco P, Ferraris A, Andriulli A, Vecchi M, Ardizzone S, Cottone M, Dallapiccola B, Rappaport E, Fortina P, Devoto M 2003 Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations. J. Med. Genet. 40: 837-841. *
Annibale B, Capurso G, Baccini F, Lahner E, D'Ambra G, Di Giulio E, Delle Fave G 2003 Role of small bowel investigation in iron deficiency anaemia after negative endoscopic/histologic evaluation of the upper and lower gastrointestinal tract. Dig. Liver Dis. 35: 784-787.
Annilo T, Chen ZQ, Shulenin S, Dean M 2003 Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. Mamm. Genome 14: 7-20. *
Ansell SM, Ackerman MJ, Black JL, Roberts LR, Tefferi A 2003 Primer on medical genomics. Part VI: Genomics and molecular genetics in clinical practice. Mayo Clin. Proc. 78: 307-317. *
Anzai C, Morokawa N, Okada H, Kamidono S, Eto Y, Yoshimura K 2003 CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J. Cyst. Fibros. 2: 14-18.
Appleby MW, Ramsdell F 2003 A forward-genetic approach for analysis of the immune system. Nat. Rev. Immunol. 3: 463-471. *
Aqel B, Bishop M, Krishna M, Cangemi J 2003 Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature. Dig. Dis. Sci. 48: 2323-2327. *
Aqui NA, Stein SH, Konkle BA, Abrams CS, Strobl FJ 2003 Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J. Clin. Apher. 18: 51-54.
Aquilina P, Savage NW, Lynham A 2003 Crohn's disease with oral presenting signs masquerading as chronic osteomyelitis. Aust. Dent. J. 48: 134-137.
Araki A, Hazama S, Oka M, Hinoda Y 2003 Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer. Nippon Rinsho 61 Suppl. 7: 229-232.
Araki Y, Andoh A, Bamba H, Yoshikawa K, Doi H, Komai Y, Higuchi A, Fujiyama Y 2003 The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Oncol. Rep. 10: 1931-1936.
Arch-Ferrer JE, Smith JK, Bynon S, Eckhoff DE, Sellers MT, Bland KI, Heslin MJ 2003 Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. Am. Surg. 69: 1067-1071.
Ardaillou R 2003 Genetic polymorphisms linked to myocardial ischemia in a Japanese population. Med. Sci. (Paris) 19: 413-414.
Ardavín C 2003 Origin, precursors and differentiation of mouse dendritic cells. Nat. Rev. Immunol. 3: 582-590. *
Ardizzone S 2003 Ulcerative colitis. Orphanet encyclopedia [http://www.orpha.net/data/patho/GB/uk-UC.pdf]. *
Ardizzone S, Bollani S, Manzionna G, Colombo E, Maconi G, Imbesi V, Bianchi Porro G 2003 Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease. Ann. Ital. Chir. 74: 621-625.
Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G 2003 Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig. Liver Dis. 35: 619-627.
Arend SM, Breedveld FC, van Dissel JT 2003 TNF-alpha blockade and tuberculosis: better look before you leap. Neth. J. Med. 61: 111-119. *
Arguelles Arias F, Arguelles Martin F, Caunedo Alvarez A, Rodriguez-Tellez M, Herrerias Gutierrez JM 2003 Utility of capsule endoscopy in pediatric gastroenterology. An. Pediatr. (Barc.) 59: 586-589.
Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C 2003 Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur. J. Cancer 39: 2341-2348. *
Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM 2003 Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J. Immunol. 171: 5673-5677. *
Armuzzi A, Ahmad T, Ling KL, De Silva A, Cullen S, van Heel D, Orchard TR, Welsh KI, Marshall SE, Jewell DP 2003 Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 52: 1133-1139. *
Arnott ID, McNeill G, Satsangi J 2003 An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. Aliment. Pharmacol. Ther. 17: 1451-1457. *
Arnott ID, Satsangi J 2003 Crohn's disease or Crohn's diseases? Gut 52: 460-461. *
Arnott ID, Watts D, Satsangi J 2003 Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety. Pharmacol. Res. 47: 1-10. *
Arrese M, Accatino L 2003 Is intrahepatic cholestasis of pregnancy an MDR3-related disease? Gastroenterology 125: 1922-1923. *
Arrese M, Trauner M 2003 Molecular aspects of bile formation and cholestasis. Trends Mol. Med. 9: 558-564. *
Arrese M, Trauner M, Ananthanarayanan M, Pizarro M, Solis N, Accatino L, Soroka C, Boyer JL, Karpen SJ, Miquel JF, Suchy FJ 2003 Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J. Hepatol. 38: 148-155. *
Arroyo V, Colmenero J 2003 Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J. Hepatol. 38 Suppl. 1: S69-S89. *
Arroyo V, Colmenero J 2003 Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict. Dig. Liver Dis. 35: 668-672.
Arslan S, Kav T, Besisik F, Kaymakoglu S, Pinarbasi B, Tozun N, Hamzaoglu HO, Duman D, Ulker A, Parlak E, Palabiyikoglu M, Dokmeci A 2003 Clinical outcome of Crohn's disease treated with infliximab. Hepatogastroenterology 50: 952-956.
Arthur LG, Kuenzler KA, Schwartz MZ 2003 Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model. J. Gastrointest. Surg. 7: 1062-1068.
Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG 2003 HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum. 48: 2567-2572. *
Asherson RA, Cervera R 2003 Unusual manifestations of the antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 25: 61-78.
Ashrafian H 2003 Hepcidin: the missing link between hemochromatosis and infections. Infect. Immun. 71: 6693-6700. *
Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ 2003 Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol. 23: 504-517. *
Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ 2003 Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. J. Lab. Clin. Med. 142: 385-390. *
Asnani S, Theuma P, Fonseca VA 2003 PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease. Metab. Syndr. Relat. Disord. 1: 23-32.
Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BA, Peters GJ, Jansen G 2003 Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. J. Biol. Chem. 278: 6680-6686. *
Asumalahti K, Ameen M, Suomela S, Hagforsen E, Michaelsson G, Evans J, Munro M, Veal C, Allen M, Leman J, David Burden A, Kirby B, Connolly M, Griffiths CE, Trembath RC, Kere J, Saarialho-Kere U, Barker JN 2003 Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J. Invest. Dermatol. 120: 627-632. *
Asumalahti K, Laitinen T, Lahermo P, Suomela S, Itkonen-Vatjus R, Jansen C, Karvonen J, Karvonen SL, Reunala T, Snellman E, Uurasmaa T, Saarialho-Kere U, Kere J 2003 Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1. J. Invest. Dermatol. 121: 735-740. *
Atalay G, Cardoso F, Paesmans M, Goldberg RM, Bleiberg H 2003 Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice? Anticancer Drugs 14: 703-713.
Atarod L, Raissi A, Aghamohammadi A, Farhoudi A, Khodadad A, Moin M, Pourpak Z, Movahedi M, Charagozlou M, Rezaei N 2003 A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in Children's Hospital Medical Center. Iran. J. Allergy Asthma Immunol. 2: 75-79.
Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J 2003 Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 52: 181-185. *
Aucan C, Walley AJ, Hennig BJ, Fitness J, Frodsham A, Zhang L, Kwiatkowski D, Hill AV 2003 Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 4: 275-282. *
Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, Omiecinski CJ 2003 Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res. 31: 3194-3207. *
Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem BS, Theodor L, Paret G, Yahav Y 2003 Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests. Clin. Exp. Med. 3: 119-123. *
Augoustides-Savvopoulou P, Luka Z, Karyda S, Stabler SP, Allen RH, Patsiaoura K, Wagner C, Mudd SH 2003 Glycine N-methyltransferase deficiency: a new patient with a novel mutation. J. Inherit. Metab. Dis. 26: 745-759. *
Aune TM, Maas K, Moore JH, Olsen NJ 2003 Gene expression profiles in human autoimmune disease. Curr. Pharm. Des. 9: 1905-1917.
Autran B, Debre P, Walker B, Katlama C 2003 Therapeutic vaccines against HIV need international partnerships. Nat. Rev. Immunol. 3: 503-508.
Auvin S, Dalle JH, Ganga-Zandzou PS, Ythier H 2003 Is agranulocytosis following infectious mononucleosis caused by autoimmunity? Pediatr. Hematol. Oncol. 20: 611-615.
Auwerx J, Cock TA, Knouff C 2003 PPAR-gamma: a thrifty transcription factor. Nucl. Recept. Signal. 1: e006. *
Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, Megraud F 2003 Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect. Immun. 71: 3667-3672. *
Awada H, Abi-Karam G, Fayad F 2003 Musculoskeletal and other extrapulmonary disorders in sarcoidosis. Best Pract. Res. Clin. Rheumatol. 17: 971-987.
Awadallah S, Hamad M 2003 A study of haptoglobin phenotypes in patients with chronic renal failure. Ann. Clin. Biochem. 40: 680-683.
Ayala de la Cruz Mdel C, Gonzalez Diaz R, Lopez Lara ND 2003 Wegener's granulomatosis. Report of a pediatric case and review of the literature. Rev. Alerg. Mex. 50: 71-75.
Aydogdu S, Ozgenc F, Yurtsever S, Akman SA, Tokat Y, Yagci RV 2003 Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J. Trop. Pediatr. 49: 367-370. *
Azzali G 2003 Structure, lymphatic vascularization and lymphocyte migration in mucosa-associated lymphoid tissue. Immunol. Rev. 195: 178-189. *
Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr 2003 Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. U.S.A. 100: 3031-3034. *
Babron MC, Nilsson S, Adamovic S, Naluai AT, Wahlstrom J, Ascher H, Ciclitira PJ, Sollid LM, Partanen J, Greco L, Clerget-Darpoux F; European Genetics Cluster on Coeliac Disease 2003 Meta and pooled analysis of European coeliac disease data. Eur. J. Hum. Genet. 11: 828-834. *
Baburajan B, Parkes M 2003 The genetics of inflammatory bowel disease. Hosp. Med. 64: 599-602.
Baccarani U, Risaliti A, Sainz-Barriga M, Adani GL, Donini A, Toniutto P, Bresadola F 2003 Ileosplenic fistula and splenic abscesses caused by migration of biliary stents in a liver transplant recipient. Gastrointest. Endosc. 58: 811-813.
Bach JF 2003 Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3: 189-198. *
Bach N, Bodian C, Bodenheimer H, Croen E, Berk PD, Thung SN, Lindor KD, Therneau T, Schaffner F 2003 Methotrexate therapy for primary biliary cirrhosis. Am. J. Gastroenterol. 98: 187-193. *
Bach N, Odin JA 2003 Primary biliary cirrhosis: a Mount Sinai perspective. Mt. Sinai J. Med. 70: 242-250. *
Bachmeyer C, Charoud A, Turc Y, Callot V, Blum L, Aractingi S 2003 Isotretinoin-induced bilateral sacroiliitis. Dermatology 206: 285-286.
Badenhoop K, Seidl C 2003 Fine-tuning of T lymphocytes in autoimmunity: genetic association of CTLA-4 variants and Graves' disease revisited. Clin. Endocrinol. (Oxf.) 59: 555-557. *
Bader TR, Beavers KL, Semelka RC 2003 MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226: 675-685. *
Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P 2003 Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N. Engl. J. Med. 348: 601-608. *
Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST 2003 Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. U.S.A. 100: 1751-1756. *
Bahillo P, Cantero T, Solis P, Aragon P, Gomez S, Cambronero R 2003 Hyper-IgM syndrome with CHARGE association. Pediatr. Allergy Immunol. 14: 487-489.
Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M 2003 Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol. 3: 27. *
Bai J, Odin JA 2003 Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun. Rev. 2: 36-42. *
Bailey LB 2003 Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133: 3748S-3753S. *
Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, Leahy DT, Vaughan P, Keegan D, O'Morain C, O'Donoghue D, Shanahan F, Parfrey NA, Quane KA 2003 Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur. J. Hum. Genet. 11: 237-244. *
Baixauli J, Kiran RP, Delaney CP 2003 Investigation and management of ischemic colitis. Cleve. Clin. J. Med. 70: 920-921, 925-926, 928-930. *
Bak D, Sobczynska-Tomaszewska A, Bal J 2003 Hereditary aspects of pancreatitis. Med. Wieku. Rozwoj. 7: 57-66.
Bak-Romaniszyn L, Planeta-Malecka I, Czkwianianc E, Rozynek E, Dzierzanowska D, Laszewicz W 2003 Drug sensitivity of Helicobacter pylori strains in children and young people from the region of Lodz. Med. Wieku. Rozwoj. VII: 129-135.
Baker DE 2003 Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy. Rev. Gastroenterol. Disord. 3: 150-157. *
Baker DE 2003 Bioequivalence of azathioprine products. Rev. Gastroenterol. Disord. 3: 219-223. *
Bakland G, Nordvag BY, Nossent HC 2003 Efficacy of anti-tumour necrosis factor alpha therapy with etanercept in chronic polyarthritis. Tidsskr. Nor. Laegeforen. 123: 2561-2564.
Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS 2003 Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am. J. Gastroenterol. 98: 833-838. *
Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP 2003 Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 4: 533-540. *
Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, FitzGerald O 2003 Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 48: 1408-1413. *
Balistreri WF 2003 Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases.
Ballot E, Bruneel A, Labas V, Johanet C 2003 Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin. Chem. 49: 634-643. *
Balotescu C, Israil A, Radu R, Alexandru I, Dobre G 2003 Aspects of constitutive and acquired antibioresistance in Aeromonas hydrophila strains isolated from water sources. Roum. Arch. Microbiol. Immunol. 62: 179-189.
Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV Jr, Yawn BP, Dickson ER, Melton LJ 3rd 2003 Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125: 1364-1369. *
Bamias G, Martin C 3rd, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, Pizarro TT, Wei P, Cominelli F 2003 Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171: 4868-4874. *
Bamias G, Sugawara K, Pagnini C, Cominelli F 2003 The Th1 immune pathway as a therapeutic target in Crohn's disease. Curr. Opin. Investig. Drugs 4: 1279-1286.
Ban M, Sawcer SJ, Heard RN, Bennetts BH, Adams S, Booth D, Perich V, Setakis E, Compston A, Stewart GJ 2003 A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients. J. Neuroimmunol. 143: 60-64.
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y 2003 Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4: 586-593. *
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y 2003 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124. *
Ban Y, Tomer Y 2003 The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379.
Banares Canizares R, Catalina Rodriguez MV 2003 Indications and therapeutic possibilities of albumin dialysis (MARS). Rev. Esp. Enferm. Dig. 95: 876-889.
Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, Carroll RJ, Chapkin RS 2003 Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic. Biol. Med. 35: 149-159.
Banerjee B 2003 The light at the end of the tunnel. Inflamm. Bowel Dis. 9: 395. *
Bangert C, Friedl J, Stary G, Stingl G, Kopp T 2003 Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? J. Invest. Dermatol. 121: 1409-1418. *
Banks C, Bateman A, Payne R, Johnson P, Sheron N 2003 Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199: 28-35. *
Banyer JL, Halliday DC, Thomson SA, Hamilton NH 2003 Combinations of IFN-gamma and IL-4 induce distinct profiles of dendritic cell-associated immunoregulatory properties. Genes Immun. 4: 427-440. *
Banz A, Peixoto A, Pontoux C, Cordier C, Rocha B, Papiernik M 2003 A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis. Eur. J. Immunol. 33: 2419-2428. *
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR 2003 Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family. Ann. N. Y. Acad. Sci. 1005: 348-351.
Bar-Oz B, Bulkowstein M, Benyamini L, Greenberg R, Soriano I, Zimmerman D, Bortnik O, Berkovitch M 2003 Use of antibiotic and analgesic drugs during lactation. Drug Saf. 26: 925-935.
Barak AJ, Beckenhauer HC, Mailliard ME, Kharbanda KK, Tuma DJ 2003 Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J. Nutr. 133: 2845-2848. *
Barbier M, Vidal H, Desreumaux P, Dubuquoy L, Bourreille A, Colombel JF, Cherbut C, Galmiche JP 2003 Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 27: 987-991. *
Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, Staels B 2003 Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J. Biol. Chem. 278: 32852-32860. *
Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B 2003 FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124: 1926-1940. *
Barbier O, Villeneuve L, Bocher V, Fontaine C, Torra IP, Duhem C, Kosykh V, Fruchart JC, Guillemette C, Staels B 2003 The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J. Biol. Chem. 278: 13975-13983. *
Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I 2003 Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19: 837-842. *
Barbuscia M, Pratico C, Di Pietro N, Rizzo AG, Melita G, De Luca M, Castriciano G, Vita F, Sano M, Gorgone S 2003 Diagnosis and treatment of Crohn's disease. G. Chir. 24: 428-434.
Barcelo-Coblijn G, Kitajka K, Puskas LG, Hogyes E, Zvara A, Hackler L Jr, Farkas T 2003 Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim. Biophys. Acta 1632: 72-79. *
Bardaro T, Falco G, Sparago A, Mercadante V, Gean Molins E, Tarantino E, Ursini MV, D'Urso M 2003 Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion. Hum. Mutat. 21: 8-11.
Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L et al 2003 A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348: 891-899. *
Barone M, Maiorano E, Ladisa R, Cuomo R, Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla A, Di Leo A, Ierardi E 2003 Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 37: 880-886. *
Barrison AF, Smith C, Oviedo J, Heeren T, Schroy PC 3rd 2003 Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am. J. Gastroenterol. 98: 1410-1416. *
Barta Z, Csipo I, Szabo GG, Szegedi G 2003 Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J. Gastroenterol. 9: 2308-2312. *
Bartfai Z, Gaede KI, Russell KA, Murakozy G, Muller-Quernheim J, Specks U 2003 Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin. Immunol. 109: 330-337. *
Barthet M, Dubucquoy L, Garcia S, Gasmi M, Desreumaux P, Colombel JF, Grimaud JC, Iovanna J, Dagorn JC 2003 Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol. Clin. Biol. 27: 895-900. *
Bartnik W 2003 Inflammatory bowel disease - Polish contribution. J. Physiol. Pharmacol. 54 Suppl. 3: 205-210. *
Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J, Donn R 2003 Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4: 487-491. *
Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM 2003 Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones 8: 329-334. *
Bartram SA, Peaston RT, Rawlings DJ, Francis RM, Thompson NP 2003 A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment. Pharmacol. Ther. 18: 1121-1127. *
Bartunkova J, Tesar V, Sediva A 2003 Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin. Immunol. 106: 73-82. *
Barutca S, Kadikoylu G, Meydan N, Bolaman Z, Gokcen A, Bal F 2003 Two autoimmune diseases: Hashimoto's thyroiditis and vitiligo accompanying breast cancer; a coincidence? J. BUON 8: 177-179.
Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, Navone R, Beri R, Millo E, Margonato A, Martinelli N, Puccetti A 2003 Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 362: 1971-1977. *
Bassas A, Chehab M, Hebby H, Al Shahed M, Al Husseini H, Al Zahrani A, Wali S 2003 Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis. Transplant. Proc. 35: 3003-3005. *
Bataller R, North KE, Brenner DA 2003 Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37: 493-503. *
Bathon JM, Genovese MC 2003 The Early Rheumatoid Arthritis (ERA) trial comparing the efficacy and safety of etanercept and methotrexate. Clin. Exp. Rheumatol. 21 (5 Suppl. 31): S195-S197.
Batra AK, Levey JM, Trister J, Patwardhan R 2003 Pyoderma gangrenosum in a patient with collagenous colitis. J. Am. Acad. Dermatol. 49: 277-279.
Batra Y, Acharya SK 2003 Acute liver failure: prognostic markers. Indian J. Gastroenterol. 22 Suppl. 2: S66-S68.
Baughman RP, Iannuzzi M 2003 Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs 17: 425-431.
Baughman RP, Koehler A, Bejarano PA, Lower EE, Weber FL Jr 2003 Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch. Intern. Med. 163: 615-620. *
Baughman RP, Lower EE, du Bois RM 2003 Sarcoidosis. Lancet 361: 1111-1118. *
Baumann U, Schmidt RE, Gessner JE 2003 New insights into the pathophysiology and in vivo function of IgG Fc receptors through gene deletion studies. Arch. Immunol. Ther. Exp. (Warsz.) 51: 399-406.
Baumert TF 2003 Novel vaccine strategies. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 58-59. October 20 - 21. *
Baumgart DC, Dignass AU 2003 Tacrolimus (FK506) in refractory ulcerative colitis: an alternative to proctocolectomy? Z. Gastroenterol. 41: 478-479.
Baumgart DC, Wiedenmann B, Dignass AU 2003 Biologic therapy of inflammatory bowel disease. Z. Gastroenterol. 41: 1017-1032.
Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE 2003 Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br. J. Plast. Surg. 56: 328-333.
Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE 2003 Genetic susceptibility to Dupuytren disease: association of Zf9 transcription factor gene. Plast. Reconstr. Surg. 111: 2133-2139.
Bayle FJ, Bouvard MP 2003 Anorexia nervosa and Crohn's disease dual diagnosis: a case study. Eur. Psychiatry 18: 421-422.
Bayley JP, Baggen JM, van der Pouw-Kraan T, Crusius JB, Huizinga TW, Verweij CL 2003 Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis. Tissue Antigens 62: 170-174. *
Bayley JP, Bakker AM, Kaijzel EL, Huizinga TW, Verweij CL 2003 Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis. Rheumatology (Oxford) 42: 969-971. *
Beamer LJ 2003 Structure of human BPI (bactericidal/permeability-increasing protein) and implications for related proteins. Biochem. Soc. Trans. 31: 791-794. *
Beath SV 2003 Hepatic function and physiology in the newborn. Semin. Neonatol. 8: 337-346.
Beckebaum S, Cicinnati V, Broelsch CE 2003 Liver transplantation, rejection and disease recurrence. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 55-56. October 15-16. *
Becker A, Smulders YM, van Guldener C, Stehouwer CD 2003 Epidemiology of homocysteine as a risk factor in diabetes. Metab. Syndr. Relat. Disord. 1: 105-120.
Becker C, Wirtz S, Blessing M, Pirhonen J, Strand D, Bechthold O, Frick J, Galle PR, Autenrieth I, Neurath MF 2003 Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112: 693-706. *
Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J 2003 Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur. J. Endocrinol. 148: 13-18. *
Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U, Hiromatsu Y, Nauman J 2003 Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin. Endocrinol. (Oxf.) 59: 519-525. *
Beehler BC, Hei YJ, Chen S, Lupisella JA, Ostrowski J, Starrett JE, Tortolani D, Tramposch KM, Reczek PR 2003 Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis. J. Rheumatol. 30: 355-363.
Befeler AS 2003 New developments in hepatocellular carcinoma. 54th Annual Meeting of the American Association for the Study of Liver Diseases.
Beghe B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW 2003 Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin. Exp. Allergy 33: 1111-1117. *
Beglinger Ch 2003 Treatment of Crohn's disease. Ther. Umsch. 60: 159-163.
Beil WJ, McEuen AR, Schulz M, Wefelmeyer U, Kraml G, Walls AF, Jensen-Jarolim E, Pabst R, Pammer J 2003 Selective alterations in mast cell subsets and eosinophil infiltration in two complementary types of intestinal inflammation: ascariasis and Crohn's disease. Pathobiology 70: 303-313.
Bejaoui M, Mellouli F, Chouanine R, Dellagi K, Barbouche MR 2003 The hyper-IgM syndrome: 13 observations. Presse. Med. 32: 544-549.
Belaiche J, Louis E 2003 Early obstructive colon after treatment of active refractory Crohn's disease with infliximab. Gastroenterol. Clin. Biol. 27: 1045.
Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA 2003 Evaluation of Helicobacter species in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18: 481-486. *
Bellamy R 2003 Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun. 4: 4-11. *
Bellanti JA, Zeligs BJ, Malka-Rais J, Sabra A 2003 Abnormalities of Th1 function in non-IgE food allergy, celiac disease, and ileal lymphonodular hyperplasia: a new relationship? Ann. Allergy Asthma Immunol. 90: 84-89.
Beltowski J, Wojcicka G, Jamroz A 2003 Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy. Postepy. Hig. Med. Dosw. 57: 199-217.
Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, Pappo O, Sulkes J, Neuman MG, Kaganovsky E, Kfir B, Tur-Kaspa R, Klein T 2003 Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J. Intern. Med. 254: 168-175. *
Benahmed M, Mention JJ, Matysiak-Budnik T, Cerf-Bensussan N 2003 Celiac disease: a future without gluten-free diet?? Gastroenterology 125: 1264-1267. *
Bencsath M, Blaskovits A, Borvendeg J 2003 Biomolecular cytokine therapy. Pathol. Oncol. Res. 9: 24-29. *
Bender IB 2003 Paget's disease. J. Endod. 29: 720-723.
Benharouga M, Sharma M, So J, Haardt M, Drzymala L, Popov M, Schwapach B, Grinstein S, Du K, Lukacs GL 2003 The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia. J. Biol. Chem. 278: 22079-22089. *
Beniwal RS, Arena VC, Thomas L, Narla S, Imperiale TF, Chaudhry RA, Ahmad UA 2003 A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Dig. Dis. Sci. 48: 2077-2082. *
Benjaminov FS, Prentice M, Sniderman KW, Siu S, Liu P, Wong F 2003 Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 52: 1355-1362. *
Bentinger M, Turunen M, Zhang XX, Wan YJ, Dallner G 2003 Involvement of retinoid X receptor alpha in coenzyme Q metabolism. J. Mol. Biol. 326: 795-803. *
Bentrem DJ, Joehl RJ 2003 Pancreas: healing response in critical illness. Crit. Care Med. 31: S582-S589.
Beranek H, Teich N, Witt H, Schulz HU, Mossner J, Keim V 2003 Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur. J. Gastroenterol. Hepatol. 15: 1223-1227.
Bergasa NV 2003 Pruritus and fatigue in primary biliary cirrhosis. Clin. Liver Dis. 7: 879-900.
Bergasa NV 2003 Management of complications of cholestasis: pruritus, fatigue and bone disease. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 54. October 15-16. *
Bergasa NV 2003 Studying pruritus in the 21st century. Clin. Gastroenterol. Hepatol. 1: 249-251. *
Berger J, Kowdley KV 2003 Is silymarin hepatoprotective in alcoholic liver disease? J. Clin. Gastroenterol. 37: 278-279.
Bergquist A 2003 Tumor markers and genetic markers in the diagnosis of bile duct carcinoma. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 91. October 15-16. *
Bernal W 2003 Changing patterns of causation and the use of transplantation in the United Kingdom. Semin. Liver Dis. 23: 227-237.
Bernard D, Christophe A, Delanghe J, Langlois M, De Buyzere M, Comhaire F 2003 The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism. Redox Rep. 8: 41-46.
Bernardino AL, Guarita DR, Mott CB, Pedroso MR, Machado MC, Laudanna AA, Tani CM, Almeida FL, Zatz M 2003 CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients. JOP 4: 169-177. *
Bernstein CL, Stiffler HL, Jowell PS, Branch MS, Baillie J 2003 Classifying low-grade dysplasia (LGD) as "negative" for malignancy increases the specificity but not the sensitivity of biliary brush cytology in primary sclerosing cholangitis (PSC). Gastrointest. Endosc. 57: AB198.
Bernstein CN, Bector S, Leslie WD 2003 Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am. J. Gastroenterol. 98: 2468-2473. *
Bernstein CN, Blanchard JF, Metge C, Yogendran M 2003 Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am. J. Gastroenterol. 98: 2784-2788. *
Bernstein CN, Leslie WD 2003 The pathophysiology of bone disease in gastrointestinal disease. Eur. J. Gastroenterol. Hepatol. 15: 857-864.
Bernstein CN, Nayar G, Hamel A, Blanchard JF 2003 Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J. Clin. Microbiol. 41: 4986-4990. *
Bernuau J 2003 Hepatic complications of pregnancy. Rev. Prat. 53: 1889-1893.
Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cezard JP, Zouali H, Emilie D, Peuchmaur M 2003 Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52: 840-846. *
Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen H, Pedersen JI 2003 Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin. Sci. (Lond.) 105: 13-20. *
Berthiaume F, MacDonald AD, Kang YH, Yarmush ML 2003 Control analysis of mitochondrial metabolism in intact hepatocytes: effect of interleukin-1beta and interleukin-6. Metab. Eng. 5: 108-123. *
Bertolotti M, Zambianchi L, Carulli L, Simonini MS, Del Puppo M, Kienle MG, Loria P, Pinetti A, Carulli N 2003 Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption. Hepatology 38: 939-946. *
Betterle C, Zanchetta R 2003 Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. Ateneo. Parmense. 74: 9-33.
Bettinardi N, Felicetta I, Tomasi PA, Colombo C 2003 Carbohydrate 19-9 antigen is not a marker of liver disease in patients with cystic fibrosis. Clin. Chem. Lab. Med. 41: 311-316.
Bettoun DJ, Burris TP, Houck KA, Buck DW 2nd, Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S 2003 Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol. Endocrinol. 17: 2320-2328. *
Beuers U 2003 Mechanisms of action of ursodeoxycholic acid in cholestasis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 49-50. October 15-16. *
Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL 2003 Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J. Biol. Chem. 278: 17810-17818. *
Beumer C, Wulferink M, Raaben W, Fiechter D, Brands R, Seinen W 2003 Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307: 737-744. *
Beutler B 2003 Science review: key inflammatory and stress pathways in critical illness - the central role of the Toll-like receptors. Crit. Care 7: 39-46. *
Beutler B 2003 Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors. Annu. Rev. Pharmacol. Toxicol. 43: 609-628. *
Beutler B, Rietschel ET 2003 Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176. *
Beutler E, Hoffbrand AV, Cook JD 2003 Iron deficiency and overload. Hematology (Am. Soc. Hematol. Educ. Program) 2003: 40-61. *
Bevins CL 2003 The role of gut flora and innate immunity in pathogenesis of inflammatory bowel disease. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 58. September 12 - 13. *
Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD 2003 A role for innate immunity in type 1 diabetes? Diabetes Metab. Res. Rev. 19: 89-100.
Beytout J, Tournilhac O, Laurichesse H 2003 Asplenia and hyposplenism. Presse Med. 32: S5-S9.
Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S 2003 Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J. Am. Coll. Cardiol. 41: 2130-2137. *
Bhatnagar A, Wig JD, Majumdar S 2003 Immunological findings in acute and chronic pancreatitis. ANZ J. Surg. 73: 59-64. *
Bhattacharya R, Kowdley KV 2003 Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime? Gastroenterology 125: 615-616. *
Bi L, Triadafilopoulos G 2003 Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits. Clin. Gastroenterol. Hepatol. 1: 345-355. *
Bi LC, Kaunitz JD 2003 Gastroduodenal mucosal defense: an integrated protective response. Curr. Opin. Gastroenterol. 19: 526-532.
Biancone L, Fiori R, Tosti C, Marinetti A, Catarinacci M, De Nigris F, Simonetti G, Pallone F 2003 Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn's disease. Inflamm. Bowel Dis. 9: 343-350. *
Biancone L, Palmieri G, Lombardi A, Colantoni A, Tonelli F, Das KM, Pallone F 2003 Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am. J. Gastroenterol. 98: 2719-2726. *
Biancone L, Tosti C, Fina D, Fantini M, De Nigris F, Geremia A, Pallone F 2003 Review article: maintenance treatment of Crohn's disease. Aliment. Pharmacol. Ther. 17 Suppl. 2: 31-37.
Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, Gobbi E, Albertini A, Arosio P 2003 Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin. Chem. 49: 1981-1988. *
Bickston SJ 2003 Keeping the M in mind: recombinant human GMCSF and Crohn's disease. Inflamm. Bowel Dis. 9: 132. *
Bickston SJ, Comerford LW, Cominelli F 2003 Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523.
Bickston SJ, Cominelli F 2003 Optimal dosing of 5-aminosalicylic acid: 5 decades of choosing between politicians. Clin. Gastroenterol. Hepatol. 1: 3-4. *
Biecker E, Stieger M, Zimmermann A, Reichen J 2003 Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. Eur. J. Gastroenterol. Hepatol. 15: 423-427.
Bienvenu T 2003 Cystic fibrosis: relationship between genotype and phenotype. Arch. Pediatr. 10 Suppl. 2: 318s-324s.
Bihl F, Salez L, Beaubier M, Torres D, Lariviere L, Laroche L, Benedetto A, Martel D, Lapointe JM, Ryffel B, Malo D 2003 Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice. J. Immunol. 170: 6141-6150. *
Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C 2003 Predictive factors for early mortality following liver transplantation. Clin. Transplant. 17: 401-411. *
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L 2003 HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann. N. Y. Acad. Sci. 1005: 314-318.
Bishop-Bailey D, Wray J 2003 Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins Other Lipid Mediat. 71: 1-22.
Bismuth M, Aguilar-Martinez P, Michel H 2003 Hereditary haemochromatosis. Presse. Med. 32: 1716-1723.
Bistrian BR 2003 Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads Lecture. JPEN J. Parenter. Enteral Nutr. 27: 168-175. *
Biswas P, Mantelli B, Hasson H, Vecchi A, Saniabadi A, Lazzarin A, Beretta A 2003 In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Clin. Immunol. 109: 355-358. *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC 2003 Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am. J. Gastroenterol. 98: 1616-1620. *
Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC 2003 Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 18: 1061-1066. *
Bitton A, Sewitch MJ, Peppercorn MA, deB Edwardes MD, Shah S, Ransil B, Locke SE 2003 Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am. J. Gastroenterol. 98: 2203-2208. *
Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R 2003 IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig. Dis. Sci. 48: 2360-2365. *
Bizzaro N, Villalta D, Tonutti E, Tampoia M, Bassetti D, Tozzoli R 2003 Association of celiac disease with connective tissue diseases and autoimmune diseases of the digestive tract. Autoimmun. Rev. 2: 358-363.
Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, Einarsdottir AS, Sherwood R, Kristjansson K, Kjartansson O, Thjodleifsson B 2003 Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 125: 1598-1605. *
Bjornsson E, Chapman RW 2003 Sclerosing cholangitis. Curr. Opin. Gastroenterol. 19: 270-275.
Black M 2003 Drug hepatotoxicity. Clin. Liver Dis. 7: xi-xii. *
Blackwell JM, Searle S, Mohamed H, White JK 2003 Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 85: 197-203.
Blakelock RT, Beasley SW 2003 Infection and the gut. Semin. Pediatr. Surg. 12: 265-274.
Blanc P, Phelip JM, Bertolino JG, Atger J, Roblin X 2003 Watermelon stomach: a rare cause of iron deficiency anemia, surgically treatable; a new case with review of the literature. Ann. Chir. 128: 462-464.
Blanchet E, Beau P 2003 Efficacy of hydrostatic balloon dilatation of anastomotic Crohn's disease strictures. Gastroenterol. Clin. Biol. 27: 1105-1109.
Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C 2003 Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85: 267-273.
Blau H, Livne M, Mussaffi H 2003 Cystic fibrosis in adults: a changing scene. Isr. Med. Assoc. J. 5: 491-495.
Bliss SK, Alcaraz A, Appleton JA 2003 IL-10 prevents liver necrosis during murine infection with Trichinella spiralis. J. Immunol. 171: 3142-3147. *
Bloomfeld RS, Onken JE 2003 Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment. Pharmacol. Ther. 17: 69-73. *
Bluestone JA, Abbas AK 2003 Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257. *
Blum S, Schiffrin EJ 2003 Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr. Issues Intest. Microbiol. 4: 53-60.
Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G 2003 Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. 4: CD004525. *
Boberg KM, Egeland T, Schrumpf E 2003 Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients. Scand. J. Gastroenterol. 38: 991-995. *
Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E 2003 Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. J. Hepatol. 39: 453. *
Boberg KM, Schrumpf E 2003 Diagnosis and differential diagnosis of primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 59-60. October 15-16. *
Bochud PY, Hawn TR, Aderem A 2003 Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170: 3451-3454. *
Bocker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, Rossol S, B Sartor R, Singer MV 2003 Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin. Exp. Immunol. 131: 53-60. *
Bocko D, Bilinska M, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Gruszka E, Frydecka I 2003 Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Arch. Immunol. Ther. Exp. (Warsz.) 51: 201-205.
Boden E, Tang Q, Bour-Jordan H, Bluestone JA 2003 The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells. Novartis Found. Symp. 252: 55-63.
Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B 2003 Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J. Biol. Chem. 278: 23529-23537. *
Boedeker EC 2003 Gastrointestinal infections. Curr. Opin. Gastroenterol. 19: 1-3.
Boehncke WH 2003 Immunomodulatory drugs for psoriasis. BMJ 327: 634-635. *
Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D 2003 Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig. Liver Dis. 35: 801-805.
Bogdanos DP, Baum H, Vergani D 2003 Antimitochondrial and other autoantibodies. Clin. Liver Dis. 7: 759-777, vi.
Bohan A, Chen WS, Denson LA, Held MA, Boyer JL 2003 Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 278: 36688-36698. *
Boitier E, Gautier JC, Roberts R 2003 Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease. Comp. Hepatol. 2: 3. *
Boixeda D, Martin De Argila C, Bermejo F, Lopez Sanroman A, Hernandez Ranz F, Garcia Plaza A 2003 Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. Factors that influence Helicobacter pylori eradications success. Rev. Esp. Enferm. Dig. 95: 206-209.
Bokarewa MI, Jin T, Tarkowski A 2003 Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J. Rheumatol. 30: 1719-1724.
Bokszczanin A, Levinson AI 2003 Coexistent yellow nail syndrome and selective antibody deficiency. Ann. Allergy Asthma Immunol. 91: 496-500.
Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, Suoraniemi E, Partanen J, Mustalahti K, Maki M, Momigliano-Richiardi P 2003 Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 61: 308-316. *
Bolondi L 2003 Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol. 39: 1076-1084. *
Bombieri C, Belpinati F, Pignatti PF, Luisetti M 2003 Comment on 'CFTR gene mutations in sarcoidosis'. Eur. J. Hum. Genet. 11: 553-554. *
Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME 2003 Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22: 5551-5560. *
Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF; Getaid 2003 Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment. Pharmacol. Ther. 18: 401-408. *
Bonen DK, Cho JH 2003 The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536. *
Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G 2003 Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124: 140-146. *
Boniotto M, Braida L, Ventura A, Percopo S, Amoroso A, Crovella S 2003 Promoter polymorphisms of the CD14 gene in Italian patients with coeliac disease. J. Med. Genet. 40: e108. *
Boniotto M, Radillo O, Braida L, Pirulli D, Citta A, Not T, Amoroso A, Crovella S 2003 Detection of MBL-2 gene expression in intestinal biopsies of celiac patients by in situ reverse transcription polymerase chain reaction. Eur. J. Histochem. 47: 177-180.
Boniotto M, Tossi A, DelPero M, Sgubin S, Antcheva N, Santon D, Masters J, Crovella S 2003 Evolution of the beta defensin 2 gene in primates. Genes Immun. 4: 251-257. *
Boone DL, Ma A 2003 Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease. J. Clin. Invest. 111: 1284-1286. *
Borchers AT, Keen CL, Gershwin ME 2003 Use and misuse of corticosteroids. Compr. Ther. 29: 157-165.
Borchers AT, Naguwa SM, Keen CL, Gershwin ME 2003 Immunopathogenesis of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 25: 89-104.
Borchers AT, So C, Naguwa SM, Keen CL, Gershwin ME 2003 Clinical and immunologic components of sarcoidosis. Clin. Rev. Allergy Immunol. 25: 289-303.
Borda F, Oquinena S, Borobio E, Vila J, Frauca A, Martinez B 2003 Is pre-operative treatment with ursodeoxycholic acid useful in reducing relapses in acute biliary pancreatitis? An. Sist. Sanit. Navar. 26: 225-229.
Borges-Walmsley MI, McKeegan KS, Walmsley AR 2003 Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376: 313-338. *
Borini P, Guimaraes RC 2003 Noninvasive classification of liver disease in asymptomatic and oligosymptomatic male alcoholics. Braz. J. Med. Biol. Res. 36: 1367-1373. *
Bosch J 2003 Invasive imaging. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 40. October 17 - 19. *
Bosch J, Abraldes JG, Groszmann R 2003 Current management of portal hypertension. J. Hepatol. 38 Suppl. 1: S54-S68. *
Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL 2003 Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am. J. Med. Genet. A. 121A: 219-224.
Bosma PJ 2003 Inherited disorders of bilirubin metabolism. J. Hepatol. 38: 107-117. *
Bosse Y, Weisnagel SJ, Bouchard C, Despres JP, Perusse L, Vohl MC 2003 Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Quebec Family Study. J. Hum. Genet. 48: 614-621. *
Botchkarev VA 2003 Neurotrophins and their role in pathogenesis of alopecia areata. J. Investig. Dermatol. Symp. Proc. 8: 195-198. *
Botsios C, Ostuni P, Sfriso P, Furlan A, Fiocco U, Sgarabotto D, Todesco S 2003 Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects. Reumatismo. 55: 224-235.
Bott C, Lembcke B, Stein J 2003 Colorectal cancer and folate. Z. Gastroenterol. 41: 263-270.
Botti F, Carrara A, Antonelli B, Quadri F, Maino M, Cesana B, Contessini-Avesani E 2003 The minimal bowel resection in Crohn's disease: analysis of prognostic factors on the surgical recurrence. Ann. Ital. Chir. 74: 627-633.
Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A 2003 Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur. J. Hum. Genet. 11: 671-678. *
Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A 2003 Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients. Gastroenterol. Clin. Biol. 27: 901-907.
Boulanger A, McLemore P, Copeland NG, Gilbert DJ, Jenkins NA, Yu SS, Gentleman S, Redmond TM 2003 Identification of beta-carotene 15, 15'-monooxygenase as a peroxisome proliferator-activated receptor target gene. FASEB J. 17: 1304-1306. *
Boulanger MJ, Chow DC, Brevnova EE, Garcia KC 2003 Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300: 2101-2104. *
Bouma G, Strober W 2003 The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533. *
Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, Comas D 2003 Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun. 4: 132-137. *
Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA 2003 CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nat. Immunol. 4: 182-188. *
Bourlioux P, Koletzko B, Guarner F, Braesco V 2003 The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am. J. Clin. Nutr. 78: 675-683. *
Bourreille A, Doubremelle M, de la Bletiere DR, Segain JP, Toquet C, Buelow R, Galmiche JP 2003 RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Scand. J. Gastroenterol. 38: 526-532. *
Bowcock AM, Barker JN 2003 Genetics of psoriasis: the potential impact on new therapies. J. Am. Acad. Dermatol. 49: S51-S56.
Bowlus CL 2003 The role of iron in T cell development and autoimmunity. Autoimmun. Rev. 2: 73-78.
Braat H, Peppelenbosch MP, Hommes DW 2003 Interleukin-10-based therapy for inflammatory bowel disease. Expert Opin. Biol. Ther. 3: 725-731.
Braddock M 2003 Inflammatory Processes in Drug Discovery - SRI Conference. 22-23 September 2003, Philadelphia, PA, USA. IDrugs 6: 1049-1052.
Bradesi S, McRoberts JA, Anton PA, Mayer EA 2003 Inflammatory bowel disease and irritable bowel syndrome: separate or unified? Curr. Opin. Gastroenterol. 19: 336-342.
Brand DD, Kang AH, Rosloniec EF 2003 Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol. 25: 3-18. *
Brandsaeter B, Broome U, Isoniemi H, Friman S, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Olsson R, Olausson M, Kirkegaard P, Bjoro K 2003 Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl. 9: 961-969. *
Brandsaeter B, Friman S, Broome U, Isoniemi H, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Bjoro K 2003 Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand. J. Gastroenterol. 38: 1176-1183. *
Brandtzaeg P 2003 Impact of immunodeficiency on immunological hoemostasis in the gut. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 61-62. September 12 - 13. *
Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH 2003 MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet.73: 1282-1292. *
Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH 2003 Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm. Bowel Dis. 9: 281-289. *
Braun J, Sieper J 2003 Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases. Expert Opin. Biol. Ther. 3: 141-168.
Braun J, van der Heijde D 2003 Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides. Expert Opin. Investig. Drugs 12: 1097-1109.
Breban M, Said-Nahal R, Hugot JP, Miceli-Richard C 2003 Familial and genetic aspects of spondyloarthropathy. Rheum. Dis. Clin. North Am. 29: 575-594.
Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR 2003 Sex steroid hormones in primary Sjogren's syndrome. J. Rheumatol. 30: 1267-1271.
Brenner S, Srebrnik A, Goldberg I 2003 Pemphigus can be induced by topical phenol as well as by foods and drugs that contain phenols or thiols. J. Cosmet. Dermatol. 2: 161-165.
Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK 2003 Vaccines for viral diseases with dermatologic manifestations. Dermatol. Clin. 21: 349-369.
Brentnall T 2003 UC for UC: ursodiol chemoprevention for ulcerative colitis. Inflamm. Bowel Dis. 9: 338. *
Brentnall TA 2003 Molecular underpinnings of cancer in ulcerative colitis. Curr. Opin. Gastroenterol. 19: 64-68.
Brentnall TA 2003 Ursodiol: good drug makes good. Gastroenterology 124: 1139-1140. *
Bresalier RS 2003 Aspirin and the prevention of colorectal neoplasia. Gastroenterology 125: 1539-1541. *
Breuning MH, Hamdy NA 2003 From gene to disease; SLC3A1, SLC7A9 and cystinuria. Ned. Tijdschr. Geneeskd. 147: 245-247.
Brewer HB Jr, Santamarina-Fojo S 2003 New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am. J. Cardiol. 91: 3E-11E. *
Brewerton DA 2003 Discovery: HLA and disease. Curr. Opin. Rheumatol. 15: 369-373.
Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA 2003 Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361: 669-673. *
Briganti S, Picardo M 2003 Antioxidant activity, lipid peroxidation and skin diseases. What's new. J. Eur. Acad. Dermatol. Venereol. 17: 663-669. *
Brigelius-Flohe R 2003 Vitamin E and drug metabolism. Biochem. Biophys. Res. Commun. 305: 737-740. *
Brinckerhoff CE, Sporn MB 2003 Retinoids and rexinoids for the 21st century: a brave new world for arthritis. J. Rheumatol. 30: 211-213.
Brinkmeier T, Angelkort B, Frosch PJ, Herbst RA 2003 Vancomycin-induced linear IgA disease. J. Dtsch. Dermatol. Ges. 1: 212-214.
Bristow CA, Shore P 2003 Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ. Nucleic Acids Res. 31: 2735-2744. *
British Committee for Standards in Haematology, Blood Transfusion Task Force 2003 Guidelines for the use of platelet transfusions. Br. J. Haematol. 122: 10-23. *
Brodanova M 2003 Cholestasis. Vnitr. Lek. 49: 689-695.
Brodmerkel CM, Vaddi K 2003 Transgenic animals in inflammatory disease models. Curr. Opin. Biotechnol. 14: 652-658. *
Broering DC, Sterneck M, Rogiers X 2003 Living donor liver transplantation. J. Hepatol. 38 Suppl. 1: S119-S135. *
Brogan BL, Olsen NJ 2003 Drug-induced rheumatic syndromes. Curr. Opin. Rheumatol. 15: 76-80.
Brombacher F, Kastelein RA, Alber G 2003 Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24: 207-212. *
Bronner F 2003 Calcium nutrition and metabolism. Dent. Clin. North Am. 47: 209-224.
Brooklyn T, Probert C 2003 A Crohn's repertoire: T cell receptor gammadelta. Inflamm. Bowel Dis. 9: 213-214. *
Broome U 2003 Autoimmune hepatitis and overlap syndromes. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 38-39. September 12 - 13. *
Broome U, Bergquist A 2003 Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreas carcinoma in patients with primary sclerosing cholangitis. Epidemiology and risk factors. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 89-90. October 15-16. *
Brophy S, Taylor G, Blake D, Calin A 2003 The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis. J. Rheumatol. 30: 2054-2058.
Brousseau ME 2003 ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption. Curr. Opin. Lipidol. 14: 35-40.
Brousseau ME 2003 Statins, super-statins and cholesterol absorption inhibitors. IDrugs 6: 458-463.
Brown GR, Lee EL, Thiele DL 2003 TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. J. Immunol. 170: 5082-5088. *
Brown KA, Moonka D 2003 Liver transplantation. Curr. Opin. Gastroenterol. 19: 259-263.
Brown MA, Brophy S, Bradbury L, Hamersma J, Timms A, Laval S, Cardon L, Calin A, Wordsworth BP 2003 Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum. 48: 2234-2239. *
Brown RS Jr 2003 Evaluation of the potential living donor. Transplant. Proc. 35: 915-916.
Brown RS Jr, Brenner DA 2003 MELD and the practicing gastroenterologist. Gastroenterology 125: 1009. *
Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, Hoofnagle JH 2003 A survey of liver transplantation from living adult donors in the United States. N. Engl. J. Med. 348: 818-825. *
Browning J, Combes B, Mayo MJ 2003 Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 98: 2736-2741. *
Browning LM 2003 n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr. Soc. 62: 447-453. *
Bruewer M, Krieglstein CF, Utech M, Bode M, Rijcken E, Anthoni C, Laukoetter MG, Schuermann G, Senninger N 2003 Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma? World J. Surg. 27: 611-615. *
Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A 2003 Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171: 6164-6172. *
Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, Benson GD, Van de Water J, Luketic V, Roche TE, Ansari AA, Coppel RL, Gershwin ME 2003 Autoreactivity to lipoate and a conjugated form of l